AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review
Clinical Gastroenterology and Hepatology · 2026-09
DOI: 10.1016/j.cgh.2026.08.005 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Koushik K Das und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Washington University in St Louis, St Louis, Missouri. Electronic address: k.das@wustl.edu. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
DESCRIPTION: There is a demographic explosion of patients over the age of 60 expected in the United States and worldwide in the next 20 years. Pancreatic cystic lesions (PCLs) are frequently, incidentally identified in more than a quarter of patients above the age of 70 and while the vast majority of these lesions are indolent, some may develop into malignancy. Similarly, while the risk of hepatocellular carcinoma (HCC) is well established in patients with cirrhosis, the proportion of the elderly population with cirrhosis is rapidly expanding, especially in the setting of metabolic dysfunction-associated steatohepatitis. While multiple guidelines define these high-risk populations and provide recommendations on how and when to implement surveillance, these same guidelines rarely specify when to stop surveillance particularly in cases of advanced age or infirmity where the patient's attributable mortality to the surveyed condition or fitness to receive invasive treatments is unclear. In this Clinical Practice Update (CPU), we review evidence-based, patient-centered, practical approaches to assess appropriateness for PCL and HCC surveillance in older individuals, weighing the balance of potential benefit vs harms and the impact of comorbidities and life expectancy on shared decision-making. METHODS: This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through the standard procedures of Clinical Gastroenterology and Hepatology. These best practice advice statements were drawn from a review of the published literature and from expert opinion. Because systematic reviews were not performed, these best practice advice statements do not carry formal ratings regarding the quality of evidence or strength of the presented considerations Best Practice Advice Statements BEST PRACTICE ADVICE 1: Regardless of age, patients with significant comorbidities (ie, age-adjusted Charlson comorbidity index ≥3-5) with incidental pancreatic cystic lesions (PCLs), particularly low risk PCL, should be counseled against routine PCL surveillance because of the low attributable mortality to pancreatic cancer (PC) and high risks due to intervention in this population. BEST PRACTICE ADVICE 2: Patients >65 years of age with PCLs ≤15 mm in size that are stable for 5 years (no concerning growth rate of 3 mm or more per year or 6 mm or more in 2 years) with no worrisome features or high-risk stigmata (as defined by the International Association of Pancreatology) should be considered for discontinuation of surveillance after detailed shared decision-making with the patient, given the potential increased morbidity with intensive surveillance in this population. BEST PRACTICE ADVICE 3: Patients >75 years of age with PCLs
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Washington University in St Louis, St Louis, Missouri. Electronic address: k.das@wustl.edu.
- University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
- Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Das, K. K., Serper, M., & Vege, S. S. (2026). AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.08.005
Vancouver
Das KK, Serper M, Vege SS. AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.08.005
BibTeX
@article{Das2026,
author = {Das, Koushik K and Serper, Marina and Vege, Santhi Swaroop},
title = {AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.08.005}
}
EUVIMED